Goodwin Procter LLP advised Vedere Bio II, Inc. on the deal. Vedere Bio II, Inc. announced its $77 million Series A financing. Vedere is developing next generation...
Vedere Bio II’s $77 Million Series A Financing
Vedere Bio II’s $77 Million Series A Financing
Goodwin Procter LLP advised Vedere Bio II, Inc. on the deal. Vedere Bio II, Inc. announced its $77 million Series A financing. Vedere is developing next generation...